Cargando…

Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma

OBJECTIVES: The purpose of the study was to access the efficacy and response of the endoscopic transsphenoidal surgery in pituitary adenomas. METHODS: It was descriptive case study, conducted at Neurosurgery Department in collaboration with the Endocrine Unit (Medical Unit-II) Of Jinnah Post Graduat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehman, Lal, Rehman, Urooj Lal, Jabeen, Rukhshanda, Rizvi, Raza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954389/
https://www.ncbi.nlm.nih.gov/pubmed/29805418
http://dx.doi.org/10.12669/pjms.342.14002
_version_ 1783323511862853632
author Rehman, Lal
Rehman, Urooj Lal
Jabeen, Rukhshanda
Rizvi, Raza
author_facet Rehman, Lal
Rehman, Urooj Lal
Jabeen, Rukhshanda
Rizvi, Raza
author_sort Rehman, Lal
collection PubMed
description OBJECTIVES: The purpose of the study was to access the efficacy and response of the endoscopic transsphenoidal surgery in pituitary adenomas. METHODS: It was descriptive case study, conducted at Neurosurgery Department in collaboration with the Endocrine Unit (Medical Unit-II) Of Jinnah Post Graduate Medical Center Karachi from January 2015 to July 2017. Patients with sellar, supra sellar and para sellar tumors were enrolled in the study. Patients with prolactinoma and recurrent pituitary tumors were excluded. Data was analyzed using SPPS 17. RESULTS: Sixty three patients were included in the study with mean age of 42±8.34 years. There were 40(63.5%) male patients and 23(36.5%) female patients with pituitary adenoma. Headache and visual impairment were the main presentation 55(87.3%) and 56 (88.8%) respectively. Out of all these patients the pituitary adenomas, 51(81%) patients had non secretory and 12 (19%) patients had secretory tumor. Out of these pituitary adenomas 53(84.1%) were macroadenomas and 10(15.9%) were microadenoma. Post operatively marked improvement in the headache was in all 100% patients and vision improved in 54 (96.4%). The most common post operative complication was cerebrospinal fluid (CSF) leak in 10 (15.9%) with 44 (69.8%) having no post complications at all. Mortality was reported to be just 1.6% i-e one patient. CONCLUSION: The endoscopic transsphenoidal approach for pituitary adenoma is the safest procedure with marked improvement in complications and reduction in patient’s hospital stay.
format Online
Article
Text
id pubmed-5954389
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-59543892018-05-25 Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma Rehman, Lal Rehman, Urooj Lal Jabeen, Rukhshanda Rizvi, Raza Pak J Med Sci Original Article OBJECTIVES: The purpose of the study was to access the efficacy and response of the endoscopic transsphenoidal surgery in pituitary adenomas. METHODS: It was descriptive case study, conducted at Neurosurgery Department in collaboration with the Endocrine Unit (Medical Unit-II) Of Jinnah Post Graduate Medical Center Karachi from January 2015 to July 2017. Patients with sellar, supra sellar and para sellar tumors were enrolled in the study. Patients with prolactinoma and recurrent pituitary tumors were excluded. Data was analyzed using SPPS 17. RESULTS: Sixty three patients were included in the study with mean age of 42±8.34 years. There were 40(63.5%) male patients and 23(36.5%) female patients with pituitary adenoma. Headache and visual impairment were the main presentation 55(87.3%) and 56 (88.8%) respectively. Out of all these patients the pituitary adenomas, 51(81%) patients had non secretory and 12 (19%) patients had secretory tumor. Out of these pituitary adenomas 53(84.1%) were macroadenomas and 10(15.9%) were microadenoma. Post operatively marked improvement in the headache was in all 100% patients and vision improved in 54 (96.4%). The most common post operative complication was cerebrospinal fluid (CSF) leak in 10 (15.9%) with 44 (69.8%) having no post complications at all. Mortality was reported to be just 1.6% i-e one patient. CONCLUSION: The endoscopic transsphenoidal approach for pituitary adenoma is the safest procedure with marked improvement in complications and reduction in patient’s hospital stay. Professional Medical Publications 2018 /pmc/articles/PMC5954389/ /pubmed/29805418 http://dx.doi.org/10.12669/pjms.342.14002 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rehman, Lal
Rehman, Urooj Lal
Jabeen, Rukhshanda
Rizvi, Raza
Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma
title Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma
title_full Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma
title_fullStr Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma
title_full_unstemmed Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma
title_short Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma
title_sort endoscopic trans-sphenoidal surgery; efficacy and response in pituitary adenoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954389/
https://www.ncbi.nlm.nih.gov/pubmed/29805418
http://dx.doi.org/10.12669/pjms.342.14002
work_keys_str_mv AT rehmanlal endoscopictranssphenoidalsurgeryefficacyandresponseinpituitaryadenoma
AT rehmanuroojlal endoscopictranssphenoidalsurgeryefficacyandresponseinpituitaryadenoma
AT jabeenrukhshanda endoscopictranssphenoidalsurgeryefficacyandresponseinpituitaryadenoma
AT rizviraza endoscopictranssphenoidalsurgeryefficacyandresponseinpituitaryadenoma